bph/luts

Purpose The purpose of this American Urological Association (AUA) Guideline amendment is to provide a useful reference on the effective evidence-based management of male lower urinary tract symptoms secondary/attributed to BPH (LUTS/BPH). Materials and Methods The Minnesota Evidence Review...

https://www.urologyhealth.org/educational-materials/prostate-health-playbook

Prostate cancer is one of the most common cancers that affect men.

Abstract Purpose To conduct a scoping review of the existing literature and recent developments on prostatic stents for the treatment of benign prostatic hyperplasia (BPH). Methods A comprehensive search was performed on Embase, MEDLINE, and Web of Science to identify English literature...

In this episode of the Prostate Health Podcast, Dr. Steven Kaplan and Dr. Dean Alterman discuss Optilume BPH, a new treatment for benign enlargement of the prostate. Optilume BPH is a drug-coated balloon that does not require surgery or permanent implants. The doctors explain the procedure and...

https://pcri.org/

In The Dr. Geo Podcast, Dr. Geo introduces Dr. Christopher Kelly from NYU Langone Health. They discuss male urinary health, focusing on Benign Prostatic Hyperplasia (BPH) and its differentiation from other conditions. They highlight the Eurodynamic test as a crucial tool for diagnosis. Dr. Kelly...

The Optilume BPH Catheter System is a non-surgical treatment for benign prostatic hyperplasia (BPH) in aging men. It involves balloon dilation and localized transfer of paclitaxel to maintain patency. The procedure is performed using rigid cystoscopy in an office setting, without general...

Elterman gets deep! Dr. Dean Elterman, a urologist at the University of Toronto, discussed urination issues in men with prostate cancer, including BPH and overactive bladder. Valuable insights and Q&A session.

https://www.urologytimes.com/view/optilume-bph-system-officially-launches-on-world-urology-market World's first use of Optilume BPH System, a minimally invasive therapy for lower urinary tract symptoms due to BPH, performed successfully. The system combines mechanical dilation with a...

Healthcare consumers are relying on online resources to prepare for appointments and validate physician recommendations. However, the abundance of information and commercial bias on the web makes it challenging to find reliable sources. The Prostate Health Academy offers a solution. With...

Aquablation, a treatment for benign prostatic hyperplasia, has demonstrated positive outcomes with low morbidity in large prostates (>80 mL). A study found significant and sustained improvements in patient symptoms, including a decrease in International Prostate Symptom Score and an increase in...

This week on the BackTable Urology Podcast, Dr. Jose Silva invites Dr. Seth Bechis onto the show to discuss the diagnosis and treatment of BPH with Rezum, a minimally invasive surgical that uses water vapor to dissolve prostate tissue

Enlarged prostate, also known as benign prostatic hyperplasia (BPH), is a common urological condition known to cause a range of urinary problems. Fortunately, the Prostatic Artery Embolization (PAE) procedure is a minimally invasive outpatient procedure used to successfully treat BPH with a...

Interventional #radiology and #urology experts from the University of Miami Health System and Desai Sethi Urology Institute discuss the most recent advances in managing an enlarged prostate, also known as benign prostatic hyperplasia (BPH), focusing on minimally invasive options. They discuss...

“Zenflow is a novel minimally invasive surgical therapy that delivers a nitinol device into the prostatic urethra displacing the lateral lobes for improved urinary flow,” explained Dean Elterman, MD. https://www.urologytimes.com/view/zenflow-spring-system-shows-promise-in-bph The use of the...

Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures (2023) Juan V.A. Franco,Pablo Tesolin, Jae Hung Jung Abstract Lower urinary tract symptoms due to benign prostatic hyperplasia constitute a substantial burden, affecting the quality of life...

39:49-42:35 (BPH/LUTS) *Any role of herbal remedies in the treatment of symptoms of BPH? Live from AUA2023: Highlights in BPH is a panel discussion filmed during the 2023 AUA Annual Meeting! This activity is designed to increase the urologist’s understanding of how to translate the...

TAKE HOME MESSAGES #EAU23 #BPH Jean-Nicolas Cornu delivered a brilliant synopsis today of the evolving landscape of surgical solutions under investigation for male #LUTS treatments. #zenflow Zenflow, Inc. #ProVee ProVerum #FloStent Rivermark Medical, Inc. #optilume Urotronic, Inc. #Aquablation...

5-alpha reductase inhibitors use in prostatic disease and beyond (2023) Bodie Chislett, David Chen, Marlon L. Perera, Eric Chung, Damien Bolton, Liang G. Qu Abstract 5-alpha reductase inhibitors (5-ARIs) are commonly used and widely available, with benefits observed from their effect on...

The role of testosterone in men’s health: is it time for a new approach? (2022) Ananias C. Diokno Abstract Purpose Because of many unanswered questions regarding men’s health, a literature review was performed to better understand the role of testosterone and testosterone replacement therapy...

J. Curtis Nickel, MD, FRCSC, discusses recent research on the relationship between prostate cancer and the male urinary tract microbiome.

Michael E. Albo, MD, compares treatments for patients with benign prostatic hyperplasia (BPH) causing lower urinary tract symptoms (LUTS).

Testosterone Treatment and the Risk of Prostate Adverse Events (2022) Jason A. Levy, DO, MS, Arthur L. Burnett, MD, MBA, Adrian S. Dobs, MD, MHS INTRODUCTION Definition Hypogonadism is a clinical syndrome that results from failure of the testis to produce physiologic concentrations of...